← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

cbdMD, Inc. (YCBD) 10-Year Financial Performance & Capital Metrics

YCBD • • Industrial / General
HealthcareSpecialty & Generic PharmaCannabis & Hemp ProductsConsumer CBD Products
AboutcbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. It has a research partnership with the University of Mississippi to identify novel cannabinoids. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina.Show more
  • Revenue $0 -100.0%
  • EBITDA $0 +100.0%
  • Net Income -$4.38B -118150.1%
  • EPS (Diluted) -1.09 +39.1%
  • Gross Margin -
  • EBITDA Margin -
  • Operating Margin -
  • Net Margin -
  • ROE -121.07% -79.9%
  • ROIC -
  • Debt/Equity 0.11 -83.3%
  • Interest Coverage -
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Momentum leader: RS Rating 85 (top 15%)
  • ✓Share count reduced 6.7% through buybacks
  • ✓Trading at only 0.0x book value

✗Weaknesses

  • ✗Weak Piotroski F-Score: 2/9
  • ✗Trading more than 30% below 52-week high
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-
5Y-
3Y-
TTM-7.8%

Profit (Net Income) CAGR

10Y-
5Y-
3Y-
TTM87.05%

EPS CAGR

10Y-
5Y-
3Y-
TTM89.24%

ROCE

10Y Avg-71.37%
5Y Avg-14.45%
3Y Avg-43.35%
Latest-

Peer Comparison

Consumer CBD Products
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
YCBDcbdMD, Inc.11.68M1.16-1.06-100%-13.21%-41.15%0.11

Profit & Loss

Sep 2016Sep 2017Sep 2018Sep 2019Sep 2020Sep 2021Sep 2022Sep 2023Sep 2024Sep 2025
Sales/Revenue+2.03M4.47M8.42M23.65M41.88M44.48M35.4M24.16M19.48M0
Revenue Growth %-1.2%0.88%1.81%0.77%0.06%-0.2%-0.32%-0.19%-1%
Cost of Goods Sold+1.62M1.36M2.67M9.14M15.51M14.5M13.07M9.18M7.49M0
COGS % of Revenue0.8%0.3%0.32%0.39%0.37%0.33%0.37%0.38%0.38%-
Gross Profit+413.13K3.12M5.75M14.51M26.37M29.99M22.34M14.98M12M0
Gross Margin %0.2%0.7%0.68%0.61%0.63%0.67%0.63%0.62%0.62%-
Gross Profit Growth %-6.55%0.84%1.53%0.82%0.14%-0.26%-0.33%-0.2%-1%
Operating Expenses+4.15M3.36M5.63M28.88M43.95M49.6M39.56M37.47M15.31M0
OpEx % of Revenue2.04%0.75%0.67%1.22%1.05%1.12%1.12%1.55%0.79%-
Selling, General & Admin03.36M1.93M28.88M34.9M39.34M31.25M18.14M12.62M0
SG&A % of Revenue-0.75%0.23%1.22%0.83%0.88%0.88%0.75%0.65%-
Research & Development0000424.45K1.42M633.39K173.04K39.02K0
R&D % of Revenue----0.01%0.03%0.02%0.01%0%-
Other Operating Expenses4.15M05.63M09.05M8.84M7.67M7.52M2.65M0
Operating Income+-3.73M-239.29K117.1K19.14M-17.58M-19.62M35.81M-9.27M-3.19M0
Operating Margin %-1.84%-0.05%0.01%0.81%-0.42%-0.44%1.01%-0.38%-0.16%-
Operating Income Growth %-0.94%1.49%162.48%-1.92%-0.12%2.83%-1.26%0.66%1%
EBITDA+-3.69M-168.01K339.64K19.43M-15.68M-17.36M38.78M-6.34M-1.37M0
EBITDA Margin %-1.82%-0.04%0.04%0.82%-0.37%-0.39%1.1%-0.26%-0.07%-
EBITDA Growth %-0.95%3.02%56.22%-1.81%-0.11%3.23%-1.16%0.78%1%
D&A (Non-Cash Add-back)44.94K71.28K222.55K289.57K1.9M2.25M2.97M2.93M1.82M0
EBIT-3.73M-860.54K355.08K-14.36M-17.58M-24.26M-17.31M-9.27M-3.32M0
Net Interest Income+-154.98K-500.63K-95575.07K39.88K-28.93K16.25K63.7K-29.51K0
Interest Income00075.07K39.88K016.25K63.7K00
Interest Expense154.98K500.63K9550028.93K0029.51K0
Other Income/Expense-154.98K-1.12M0-32.99M28.89M-4.67M-52.77M-13.67M-510.55K0
Pretax Income+-3.89M-1.36M46.83K-47.79M11.31M-24.29M-70.08M-22.94M-3.7M-4.38B
Pretax Margin %-1.91%-0.3%0.01%-2.02%0.27%-0.55%-1.98%-0.95%-0.19%-
Income Tax+8K25K-16K-2.36M-1.35M-895K0000
Effective Tax Rate %0.86%1.28%-8.8%0.95%1.11%0.96%1.06%1%1%1%
Net Income+-3.36M-1.74M-412.07K-45.43M12.6M-23.39M-74.09M-22.94M-3.7M-4.38B
Net Margin %-1.65%-0.39%-0.05%-1.92%0.3%-0.53%-2.09%-0.95%-0.19%-
Net Income Growth %-0.48%0.76%-109.25%1.28%-2.86%-2.17%0.69%0.84%-1181.5%
Net Income (Continuing)-3.9M-1.39M-1.8M-45.43M12.65M-23.39M-70.08M-22.94M-3.7M0
Discontinued Operations0000-48.98K00000
Minority Interest-656.15K937.06K1.41M0000000
EPS (Diluted)+-36.58-10.44-2.39-114.2912.19-19.16-55.80-13.32-1.79-1.09
EPS Growth %-0.71%0.77%-46.82%1.11%-2.57%-1.91%0.76%0.87%0.39%
EPS (Basic)-36.58-10.44-2.39-114.2912.47-19.16-55.80-13.32-1.79-1.09
Diluted Shares Outstanding91.75K166.49K172.22K397.49K1M1.22M1.33M2.02M4.31M4.02M
Basic Shares Outstanding91.75K166.49K172.06K397.49K980.9K1.22M1.33M2.02M4.31M4.02M
Dividend Payout Ratio----------

Balance Sheet

Sep 2016Sep 2017Sep 2018Sep 2019Sep 2020Sep 2021Sep 2022Sep 2023Sep 2024Sep 2025
Total Current Assets+956.32K3.69M11.79M15.74M23.71M36.5M16.01M8.07M6.39M0
Cash & Short-Term Investments34.26K1.14M6.49M5.49M15.1M27.44M7.72M1.8M2.45M0
Cash Only34.26K284.25K4.28M4.69M14.82M26.41M6.72M1.8M2.45M0
Short-Term Investments0859.11K2.21M798.54K276.47K1.03M1M000
Accounts Receivable163.97K1.38M4.2M2.67M911.48K1.11M1.45M1.22M983.91K0
Days Sales Outstanding29.46112.48182.2741.147.949.1414.9318.3818.43-
Inventory687.47K588.2K123.22K4.3M4.89M5.02M4.26M4.05M2.37M0
Days Inventory Outstanding155.04158.416.82171.84115.08126.46118.88161.19115.31-
Other Current Assets0583.15K589.54K1.3M1.39M1.16M703.32K750.38K406.67K0
Total Non-Current Assets+667.04K3.38M3.23M78.78M87.13M88.38M24.78M8.13M4.19M0
Property, Plant & Equipment180.28K135.48K53.48K2.47M10.83M8.71M5.55M4.07M602.79K0
Fixed Asset Turnover11.27x33.03x157.44x9.58x3.87x5.11x6.38x5.94x32.32x-
Goodwill00054.67M54.67M56.67M0000
Intangible Assets486.76K3.24M3.17M21.64M21.64M23.12M17.83M3.22M2.89M0
Long-Term Investments0000001.4M700K700K0
Other Non-Current Assets0-2.44B000-114.18K1.64B138.71K00
Total Assets+1.62M7.07M15.02M94.52M110.84M124.88M40.79M16.2M10.58M0
Asset Turnover1.25x0.63x0.56x0.25x0.38x0.36x0.87x1.49x1.84x-
Asset Growth %-3.35%1.12%5.29%0.17%0.13%-0.67%-0.6%-0.35%-1%
Total Current Liabilities+1.9M1.52M969.96K3.71M7.69M6.92M5.29M4.67M8.62M3.19B
Accounts Payable206.16K465.48K481.58K3.02M2.85M2.98M2.04M1.91M1.54M1.17B
Days Payables Outstanding46.49125.3565.75120.767.0675.0156.8975.8175.13-
Short-Term Debt797.55K000909.64K59.47K9.61K2.49K1.17M778.24M
Deferred Revenue (Current)041.42K161.46K7.34K45.14K00185.25K503.25K1000K
Other Current Liabilities0000864.5K00001.91B
Current Ratio0.50x2.42x12.16x4.24x3.08x5.28x3.03x1.73x0.74x-
Quick Ratio0.14x2.04x12.03x3.08x2.45x4.55x2.22x0.86x0.47x-
Cash Conversion Cycle138.01145.52133.3492.2955.9660.5876.92103.7558.61-
Total Non-Current Liabilities+12K397K28.5K53.2M23.97M14.82M4.08M2.49M00
Long-Term Debt0360K00602.1K00000
Capital Lease Obligations00006.01M4.86M3.68M2.4M00
Deferred Tax Liabilities12K37K21K2.24M895K00000
Other Non-Current Liabilities007.5K50.96M16.46M9.96M401.49K90.37K00
Total Liabilities1.92M1.92M998.46K56.91M31.66M21.74M9.37M7.16M8.62M3.19B
Total Debt+797.55K360K0194.47K8.68M6.07M4.87M3.68M1.27M778.24M
Net Debt763.29K75.75K-4.28M-4.5M-6.14M-20.34M-1.85M1.89M-1.18M778.24M
Debt / Equity-0.07x-0.01x0.11x0.06x0.15x0.41x0.65x0.11x
Debt / EBITDA---0.01x--0.13x---
Net Debt / EBITDA---12.61x-0.23x---0.05x---
Interest Coverage-24.09x-0.48x122.62x---678.05x---108.10x-
Total Equity+-292.73K5.15M14.02M37.6M79.18M103.14M31.42M9.03M1.96M7.23B
Equity Growth %-18.59%1.72%1.68%1.11%0.3%-0.7%-0.71%-0.78%3679.37%
Book Value per Share-3.1930.9381.4094.6078.8884.4823.674.470.461796.36
Total Shareholders' Equity363.43K4.21M12.61M37.6M79.18M103.14M31.42M9.03M1.96M7.23B
Common Stock3.4K5.79K8.12K27.72K52.13K57.78K60.67K2.96K3.94K8.92M
Retained Earnings-4.49M-6.26M-6.67M-59.61M-47.39M-73.34M-147.42M-174.36M-182.07M-179.44B
Treasury Stock0000000000
Accumulated OCI00-2.51M0000000
Minority Interest-656.15K937.06K1.41M0000000

Cash Flow

Sep 2016Sep 2017Sep 2018Sep 2019Sep 2020Sep 2021Sep 2022Sep 2023Sep 2024Sep 2025
Cash from Operations+-2.9M-2.33M-5.57M-15.38M-10.66M-14.09M-14.97M-4.3M-352.79K0
Operating CF Margin %-1.43%-0.52%-0.66%-0.65%-0.25%-0.32%-0.42%-0.18%-0.02%-
Operating CF Growth %-0.2%-1.39%-1.76%0.31%-0.32%-0.06%0.71%0.92%1%
Net Income-3.9M-1.39M62.83K-51.36M12.6M-23.39M-70.08M-22.94M-3.7M-2.04B
Depreciation & Amortization44.94K71.28K222.55K289.57K720.75K2.25M2.97M2.93M1.82M1.13B
Stock-Based Compensation11.45K212.93K678.73K2.69M2.04M2.92M928.83K342.87K16.9K0
Deferred Taxes0296.23K571.65K6.79M1.21M-471.02K0000
Other Non-Cash Items268.75K-239.45K-2.91M32.28M-27.05M7.42M53.99M14.8M2.05M914.76M
Working Capital Changes673.88K-988.43K-4.2M-6.07M-184.51K-2.82M-2.77M570.45K-538.83K0
Change in Receivables-163.82K-789.99K-991.95K-401.98K514.35K-183.74K65.54K278.48K232.18K-439.56M
Change in Inventory-519.74K-41.22K255.89K-3.12M-535.15K-1.01M-112.19K27.44K790.14K-732.92M
Change in Payables785.92K-466.99K-666.67K394.32K1.48M-740.07K-1.81M61.18K-1.12M-261.88M
Cash from Investing+-127.26K152.31K-683.56K-2.13M-1.57M-2.55M-688.68K702.45K-290.01K-184.17M
Capital Expenditures-127.26K-7.97K-383.56K-1.25M-1.32M-2.34M-688.68K-297.55K-290.01K-184.17M
CapEx % of Revenue0.06%0%0.05%0.05%0.03%0.05%0.02%0.01%0.01%-
Acquisitions----------
Investments----------
Other Investing0-39.72K-660K31.32K-250K-2M0000
Cash from Financing+2.51M2.43M10.25M17.92M22.37M28.23M-4.04M-1.32M1.3M1.45B
Debt Issued (Net)----------
Equity Issued (Net)----------
Dividends Paid0-29.18K00-366.85K-2.55M-4M-3.67M00
Share Repurchases----------
Other Financing03K-672.57K-326.87K62.2K00001.45B
Net Change in Cash----------
Free Cash Flow+-3.02M-2.34M-5.96M-16.63M-11.98M-16.44M-15.66M-4.6M-642.81K-184.17M
FCF Margin %-1.49%-0.52%-0.71%-0.7%-0.29%-0.37%-0.44%-0.19%-0.03%-
FCF Growth %-0.23%-1.55%-1.79%0.28%-0.37%0.05%0.71%0.86%-285.51%
FCF per Share-32.97-14.04-34.59-41.83-11.94-13.46-11.79-2.27-0.15-45.78
FCF Conversion (FCF/Net Income)0.86x1.34x13.52x0.34x-0.85x0.60x0.20x0.19x0.10x-
Interest Paid0000000000
Taxes Paid0000000000

Key Ratios

Metric2016201720182019202020212022202320242025
Return on Equity (ROE)--71.61%-4.3%-176.01%21.58%-25.66%-110.11%-113.4%-67.31%-121.07%
Return on Invested Capital (ROIC)-595.02%-6.3%1.17%67.02%-24.85%-18.88%47.8%-34.34%-40.9%-
Gross Margin20.34%69.71%68.25%61.37%62.96%67.41%63.09%62.01%61.57%-
Net Margin-165.22%-38.85%-4.89%-192.08%30.09%-52.6%-209.26%-94.96%-18.99%-
Debt / Equity-0.07x-0.01x0.11x0.06x0.15x0.41x0.65x0.11x
Interest Coverage-24.09x-0.48x122.62x---678.05x---108.10x-
FCF Conversion0.86x1.34x13.52x0.34x-0.85x0.60x0.20x0.19x0.10x-
Revenue Growth-120.27%88.16%180.89%77.09%6.2%-20.41%-31.77%-19.35%-100%

Frequently Asked Questions

Growth & Financials

cbdMD, Inc. (YCBD) reported $19.0M in revenue for fiscal year 2025. This represents a 837% increase from $2.0M in 2016.

cbdMD, Inc. (YCBD) saw revenue decline by 100.0% over the past year.

cbdMD, Inc. (YCBD) reported a net loss of $2.5M for fiscal year 2025.

Dividend & Returns

cbdMD, Inc. (YCBD) has a return on equity (ROE) of -121.1%. Negative ROE indicates the company is unprofitable.

cbdMD, Inc. (YCBD) had negative free cash flow of $688.0M in fiscal year 2025, likely due to heavy capital investments.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.